1. Bridging therapy by azacitidine in a patient with atypical chronic myeloid leukemia, followed by human leukocyte antigen- haploidentical stem cell transplantation
    Miyo Goto et al, 2021, Japanese Journal of Transplantation and Cellular Therapy CrossRef
  2. Targeting few to help hundreds: JAK, MAPK and ROCK pathways as druggable targets in atypical chronic myeloid leukemia
    Stefania Rocca et al, 2018, Molecular Cancer CrossRef
  3. Epigenetic Therapies in the Precision Medicine Era
    Michel Lopes Leite et al, 2020, Advanced Therapeutics CrossRef
  4. Decitabine treatment for an unusual case of atypical chronic myeloid leukemia (aCML) with a concomitant chronic lymphocytic leukemia (CLL)
    Ramona Cassin et al, 2019, Hematological Oncology CrossRef
  5. Chronic neutrophilic leukemia and atypical chronic myeloid leukemia: 2024 update on diagnosis, genetics, risk stratification, and management
    Natasha Szuber et al, 2024, American Journal of Hematology CrossRef
  6. Atypical chronic myeloid leukemia: a rare entity with management challenges
    Prajwal Dhakal et al, 2018, Future Oncology CrossRef
  7. Current and evolving understanding of atypical chronic myeloid leukemia
    Lauren C. Schwartz et al, 2019, Blood Reviews CrossRef
  8. Challenges in Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)
    Brianna N. Smith et al, 2019, Clinical Lymphoma Myeloma and Leukemia CrossRef
  9. Molecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia
    Diletta Fontana et al, 2021, Frontiers in Oncology CrossRef
  10. How I treat atypical chronic myeloid leukemia
    Jason Gotlib, 2017, Blood CrossRef
  11. Atypical Chronic Myeloid Leukemia: Where Are We Now?
    Elena Crisà et al, 2020, International Journal of Molecular Sciences CrossRef
  12. Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia
    Kim-Hien T. Dao et al, 2017, Current Hematologic Malignancy Reports CrossRef
  13. Atypical Chronic Myeloid Leukemia: New Developments from Molecular Diagnosis to Treatment
    Alessia Castellino et al, 2021, Medicina CrossRef
  14. Definitions, Biology, and Current Therapeutic Landscape of Myelodysplastic/Myeloproliferative Neoplasms
    Margo B. Gerke et al, 2023, Cancers CrossRef
  15. Atypical CML: diagnosis and treatment
    Massimo Breccia, 2023, Hematology CrossRef
  16. Synergetic effect of Azacitidine and Sorafenib in treatment of a case of myeloid neoplasm with sole chromosomal abnormality t(8;22)(p11.2;q11.2)/BCR-FGFR1 rearrangement
    Somprakash Dhangar et al, 2023, Cancer Genetics CrossRef
  17. Trametinib: Could It Be a Promising Drug to Treat Atypical Chronic Myeloid Leukemia?
    Marwa Elsayed et al, 2022, Cureus CrossRef